CNN's Kaitlan Collins Is Infuriated That No One Cares About Trump Blasting Dems...
Watch Scott Jennings Slaps Down Lib Media Claim That Illegals Won't Get Health...
Wait, a Dem Rep Really Said This About Trump During the Schumer Shutdown
The Latest Sombrero-Mariachi Responses to the Schumer Shutdown Are Gold
No Apologies: Proud to Stand With Israel, Proud to Defend the West
Trump Posted a New Clip Trolling Hakeem Jeffries...and Another That's Really Going to...
Antifa Assaulted Conservative Journalists – Guess Who the Police Arrested
Democrats Thought They Had the Upper Hand in the Schumer Shutdown. WaPo Says...
Qatar Is Bankrolling Global Terror—and It’s a Direct Threat to the West
The Democrats Won’t Shut Down the Government for Long
Another Blue City Just Got Some Bad News From OMB Director Vought
Of Course This Happened Just Moments After ‘1984’ Starmer Beach Art Appeared
This 2019 Clip of Democrats Is Coming Back to Haunt Them Amid Shutdown...
Amidst Concerns About Left-Wing Lawfare, States Should Review Who They Have on Contract...
Talking Point vs. Truth
Tipsheet

There Are Now Three Coronavirus Vaccines Approved by the FDA

AP Photo/Tsafrir Abayov

The Trump era's Operation Warp Speed is the gift that keeps on giving. On Saturday, the Food and Drug Administration (FDA) approved Johnson & Johnson's Wuhan coronavirus vaccine, making it the third coronavirus vaccine approved in the United States. 

Advertisement

The agency's emergency-use approval comes one day after an advisory panel for the FDA recommended drugmaker Johnson & Johnson's vaccine candidate for approval. 

Johnson & Johnson's vaccine is the third coronavirus vaccine to receive FDA approval, but the first vaccine requiring just one shot for vaccination. The drug showed a 66 percent effectiveness against moderate to severe COVID-19 infections and about an 85 percent effectiveness against the most serious illnesses. While two other FDA-approved vaccines have efficacy rates in the 90s, Johnson & Johnson's drug was shown to prevent 100 percent of hospitalizations in a clinical study of around 44,000 participants in the United States. 

"This is a vaccine to prevent you from going to the hospital and dying at a level that’s certainly comparable" to the Pfizer and Moderna vaccines, said Dr. Paul Offit, a member of the FDA's advisory panel and vaccine expert at Children's Hospital of Philadelphia.

Advertisement

Unlike the vaccines developed by Pfizer and Moderna, Johnson & Johnson's vaccine candidate does not to be stored in freezers and remains stable for months in refrigerated temperatures.  

Around 3 to 4 million doses of the new vaccine are expected to be shipped out as early as next week. The company has pledged to deliver some 20 million doses by April and 100 million by late June.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement